13F filing recap · Q1 2015

What did Brave Warrior Advisors buy in Q1 2015?

Reported stock-position changes between this filing and the previous one.

Stock value

$3.28B

Positions

Estimated turnover

26.6%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

EQIXEquinix Inc$205.34Mreported value+881.8K shares JPMJPMorgan Chase & Co$59.10Mreported value+2.69M shares

Increased positions

JPMJPMorgan Chase & Co$291.86Mreported value+655.3K shares+15.7%SCHWSchwab Charles Corp$279.81Mreported value+717.5K shares+8.5%MSFTMicrosoft Corporation$253.26Mreported value+1.11M shares+21.7%HALHalliburton Company$244.24Mreported value+1.42M shares

Reduced positions

VRXValeant Pharmaceuticals International, Inc.$1.17Breported value-249.6K shares-4.1%ESRXExpress Scripts Holding Co$303.31Mreported value-593.1K shares-14.5%CMPRCimpress Plc$213.96Mreported value-298.1K shares-10.5%KMIKinder Morgan, Inc.$124.53Mreported value-1.23M shares

Exited positions

EQIXEquinix Inc$193.27Mprior reported value-852.4K shares-100.0%